Slopes Bio completes oversubscribed $3.8 Million Series A to expand the Slopes LabKit Platform.

Jul 25

Written By Allen Ward

Allen Ward

Singular Genomics G4 next generation sequencing platform installed at Slopes Bio, adding flexible, rapid sequencing capabilities on the Slopes Bio LabKit™

Spectrum Solutions device obtains 510(k) clearance, supported by validation work performed by Slopes Bio.